| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -24.84M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CBIO returned +13.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +44.6% |
| 1 year | +13.9% |
| 5 years | -107.0% |
| 10 years | -102.1% |
| All-time high | $2,301.00 (Feb 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CBIO would be worth today ›No. Crescent Biopharma, Inc. has not paid a dividend in the past 12 months.
Crescent Biopharma, Inc. stock trades on NASDAQ under the ticker symbol CBIO.
Crescent Biopharma, Inc. is part of the Healthcare sector.
Crescent Biopharma, Inc. has a market cap of 637.02M USD, based on the latest quote.
